2C-I
Sign in to save2C-I, also known as 4-iodo-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally.
Key facts
- Drug.Verifiedfields
- verified
- Drug.Watchedfields
- verified
- Drug.verifiedrevid
- 477216266
- Drug.image
- 2C-I2DACS.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 200px
- Drug.image2
- 2C-I-3d-sticks.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 200px
- Drug.routes_of_administration
- Oral
- Drug.class
- Serotonin 5-HT2 receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
- Drug.ATC_prefix
- None
- Drug.legal_AU
- Schedule 9
- Drug.legal_BR
- F2
- Drug.legal_CA
- Schedule III
- Drug.legal_UK
- Class A
- Drug.legal_US
- Schedule I
- Drug.onset
- ≤40 minutes
via Wikipedia infobox
Article
20 sectionsContents
- Use and effects
- Interactions
- Pharmacology
- Pharmacodynamics
- Chemistry
- Synthesis
- Analogues
- History
- Society and culture
- Legal status
- Australia
- Canada
- European Union
- Finland
- Sweden
- United Kingdom
- United States
- See also
- References
- External links
2C-I, also known as 4-iodo-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally.
2C-I was first synthesized and described by Alexander Shulgin in 1977 and was described in further detail in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved). The drug is used recreationally. 2C-I is sometimes confused with other related psychedelic drugs such as 25I-NBOMe (NBOMe-2C-I), nicknamed "Smiles" and "N-bomb" in the media.